4th Quarter - Amendment

TARPLIN, DOWNS & YOUNG, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$70,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2010 $70,000 Replaced
4th Quarter - Amendment (this page) Jan 20, 2010 $70,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

**see addendum page S. 1213 - Patient - Centered Outcomes Research Act of 2009, comparative effectiveness Biosimilars S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - the Pathway for Biosimilars Act S. 301/H.R. 3138 - Physician Payments Sunshine Act of 2009, disclosure ***, no specific bill(s), health care reform, stem cell research

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), H.R. 1427 (111th), H.R. 1548 (111th), S. 1213 (111th), H.R. 3138 (111th), S. 301 (111th)

Medicare/Medicaid MMM

**see addendum page Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, drug importation, biosimilars, 340b H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, Affordable Health Choices Act S. 1796, Americas Health Future Act of 2009 H.R. 3590, The Patient Protection and Affordable Care Act

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1796 (111th), H.R. 3590 (111th), H.R. 3200 (111th), S. 1679 (111th)

Pharmacy PHA

*see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 510 (111th), H.R. 759 (111th), S. 80 (111th), H.R. 1298 (111th), S. 525 (111th)

Copyright/Patent/Trademark CPT

**see addendum page S. 515/H.R. 1260 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 S. 369 - Preserve Access to Affordable Generics Act ***, no specific bill(s), Intellectual Property

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1260 (111th), S. 610 (111th), S. 515 (111th), S. 369 (111th)

Budget/Appropriations BUD

reconciliation instructions, health care reform H.R. 2892/S. 1298, 2010 Dept. of Homeland Security Appropriations bill, drug importation

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1298 (111th), H.R. 2892 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.